Chen Bihua

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Chen Bihua
CIK #0001599214
CIK Period
0001599214
Sector Form 13F Holdings Value ($B)
Helix Acquisition Corp 0.4
Psivida Corp 0.1
Bridgebio Pharma Inc 0.1
Praxis Precision Medicines Inc 0.1
Merus NV 0.1
Edgewise Therapeutics Inc 0.1
Insmed Inc 0.1
Arcellx Inc 0.1
Newamsterdam Pharma Co NV 0.0
Janux Therapeutics Inc 0.0
Rapport Therapeutics Inc 0.0
Verona Pharma PLC 0.0
Helix Acquisition Corp II 0.0
Bright Minds Biosciences Inc 0.0
Centessa Pharmaceuticals PLC 0.0
Pharvaris NV 0.0
GH Research PLC 0.0
Silverback Therapeutics Inc 0.0
Corbus Pharmaceuticals Holdings Inc 0.0
Abivax Sa 0.0
CG Oncology Inc 0.0
Arcutis Biotherapeutics Inc 0.0
Cargo Therapeutics Inc 0.0
Tarsus Pharmaceuticals Inc 0.0
Crinetics Pharmaceuticals Inc 0.0
Metsera Inc 0.0
Aardvark Therapeutics Inc 0.0
Axsome Therapeutics Inc 0.0
Bioage Labs Inc 0.0
Engene Holdings Inc 0.0
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2025
13F-NT [0001599214]
3 [0001599214]
4 [0001599214]
SC 13G [0001599214]
Form 13D/13G Filer Form 13D/13G Subject Filed
Chen Bihua Moonlake Immunotherapeutics [2023-03-31]
Form 3/4/5 Subject 2011 - 2025
Chen Bihua
BridgeBio Oncology Therapeutics, Inc.
Cormorant Global Healthcare Master Fund, LP
Biomea Fusion, Inc.
Cormorant Asset Management, LP
Cormorant Private Healthcare Fund III LP
Cormorant Private Healthcare Fund V LP
OnKure Therapeutics, Inc.
Cormorant Private Healthcare Fund IV LP
Aardvark Therapeutics, Inc.
View All
Terms | Privacy | Guide
tony@aum13f.com